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ABSTRACT
Background: The association between diabetes mellitus (DM) and low secretory immunoglobulin A (s-IgA)
secretion rates is one mechanism suspected of inﬂuencing susceptibility to infections among DM patients. However,
several studies have shown contradictory results. We examined these two factors to seek evidence of an association
among older people.
Methods: We analyzed a prospective cohort of 2306 subjects (1209 men and 1097 women) around 64 years old
from the New Integrated Suburban Seniority Investigation (NISSIN) Project in Nisshin, Japan. DM statuses were
ascertained from levels of fasting plasma glucose and HbA1c, and s-IgA secretion rates were obtained from 5-min
saliva samples. We used an analysis of covariance adjusted for possible confounders to compare s-IgA secretion rates
according to DM status.
Results: s-IgA secretion rates in DM participants were lower than in those classiﬁed as normal (18.6 µg/min vs
15.0 µg/min, P = 0.03), even after elimination of the effects of possible confounders.
Conclusions: DM was associated with lower s-IgA secretion rates. This suggests that lower s-IgA levels may be a
mechanism of susceptibility to infection in individuals with DM.
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INTRODUCTION
Secretory immunoglobulin A (s-IgA), the predominant
immunoglobulin in secretions of the mucosal immune
system, plays an important primary role in antigen
excretion.1 It is found in saliva, intestinal secretions,
bronchoalveolar lavage ﬂuid, urine, tears, and other mucosal
ﬂuids. It inhibits attachment and replication of pathogenic
microorganisms, thus preventing colonization of these
pathogens. It is also capable of neutralizing toxins and
viruses.1,2 A study of humans with mucosal humoral
immunodeﬁciencies suggests that the absence of s-IgA leads
to an increase in mucosal infections and respiratory tract
infections.3 Moreover, suppression of s-IgA is associated
with increased incidence of upper respiratory tract infection
(URTI) in elite athletes4,5 and healthy adults.6
Diabetes mellitus (DM) is associated with an increased
risk of morbidity from infectious diseases, such as pneumonia
and urinary tract infections.7,8 Several previous studies have
reported that DM patients have impaired chemotaxis of the
immune cells, defective phagocytosis of macrophages, and
increased production of free radicals.9,10 Hyperglycemia
can cause microangiopathy, which can lead to ulceration,
secondary infection,11 and neuropathy. Microangiopathy may
also result in impaired bladder emptying, which increases
susceptibility to urinary tract infections.12 Several mechanisms
seem to cause susceptibility to infections in patients with
diabetes. A low s-IgA secretion rate is suspected to be one
of these mechanisms; however, previous studies have shown
contradictory results.13,14 Branco-de-Almeida et al reported
that DM patients had lower mean levels of s-IgA than non-
DM patients,13 while Yavuzyilmaz et al reported that DM
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patients had higher mean levels of s-IgA than healthy
controls.14 These studies13,14 used small and limited
community samples and failed to control for factors such as
age, educational background, smoking, physical activity, or
periodontitis, which are now known to be related to both
s-IgA secretion and DM.15–17
We investigated the association between DM and s-IgA
secretion rates using data from the New Integrated Suburban
Seniority Investigation (NISSIN) Project, a large community
sample of older people.
MATERIALS AND METHODS
Study population
This cross-sectional study was conducted using baseline data
from the NISSIN Project, an age-speciﬁc prospective cohort
study in Nisshin City, which is located near Nagoya City,
Japan. Using the basic resident registry of Nisshin City,
residents aged 64 years were invited to attend a free health
check-up every April from 1996 through 2005; ultimately,
3073 subjects were recruited into this cohort (43.9% of the
eligible population). Details of the NISSIN Project have been
described elsewhere.18 Subjects were given a comprehensive
medical and dental check-up in the early morning after an
overnight fast. Participants in the present study were limited
to those recruited from 1998 until 2005, as saliva samples
were collected during this period.
Of the 2579 subjects that we approached, 2557 agreed to
participate. From these, 2492 saliva samples (from 1275
men and 1217 women) were obtained. We excluded 183
participants because too little saliva was collected for assay.
A further three participants were excluded due to missing
fasting plasma glucose (FPG) and glycated hemoglobin
(HbA1c) data. Thus, a total of 2306 subjects (1209 men and
1097 women) were analyzed.
Until 2001, oral consent was obtained using an opt-out
approach, and written consent by an opt-in approach was
used thereafter. We followed the checklist of the STROBE
(STrengthening the Reporting of OBservational studies in
Epidemiology) guidelines.19 This study was approved by the
Ethics Committees of Nagoya University Graduate School
of Medicine, the National Center for Geriatrics and
Gerontology of Japan, the Aichi Medical University School
of Medicine, and the Hokkaido University Graduate School
of Medicine.
Sample collection
The medical check-up consisted of clinical and laboratory
blood testing, including measurement of FPG and HbA1c. All
clinical tests were performed in a single laboratory. A self-
administered questionnaire was used to assess demographic
and lifestyle factors. Demographic factors included gender
and educational background. Lifestyle factors included
smoking status and physical activity.
Dentists performed a dental check-up, and community
periodontal index (CPI) codes were recorded as an estimate of
periodontitis. CPI codes of 0–4 were assigned: 0 for healthy
cases; 1 for bleeding on probing; 2 for presence of calculus; 3
for a probing pocket depth of 4–5mm, and 4 for a probing
pocket depth of ≥6mm. The highest CPI code recorded for
any of each participant’s teeth was applied to that participant.
Deﬁnition of diabetes mellitus status
Levels of HbA1c were determined via the Japan Diabetes
Society (JDS) method. JDS HbA1c (%) was converted to the
internationally used HbA1c (%) measurement as deﬁned by the
National Glycohemoglobin Standardization Program (NGSP),
using the following formula: NGSP (%) = 1.02 × JDS
(%) + 0.25 (%). DM was then classiﬁed as:
Normal: FPG <6.1mmol/l and HbA1c (NGSP) <5.6%
(38mmol/mol)20
Pre-DM: 6.1mmol/l ≤ FPG <7.0mmol/l; or 5.6% (38
mmol/mol) ≤ HbA1c (NGSP) <6.5% (48mmol/mol)20
DM: FPG ≥7.0mmol/l or HbA1c (NGSP) ≥6.5% (48
mmol/mol),20 or use of medication for DM
Use of medication for DM was obtained via the question:
“Are you taking any oral medications for DM?”. We did not
include a question about subcutaneous injection of insulin.
Salivary s-IgA analysis
Salivary s-IgA analysis was performed using the same method
as previously reported.21 Brieﬂy, to determine the volume and
concentration of saliva, samples of unstimulated saliva were
collected with two cotton swabs (Salivettes; Sarstedt Ltd.,
Leicester, UK) prior to the dental check-up. The swabs were
placed under the tongue of each participant and removed after
5 minutes, and the saliva was extracted from the cotton by
centrifugation. Then we stored the saliva samples in tubes at
−20°C until analysis. An enzyme-linked immunoabsorbent
assay (ELISA) was performed to measure the s-IgA
concentration in the saliva using an IgA test (MBL Inc.,
Santa Clara, CA, USA). ELISA was performed once a year
from 1998 until 2005, and the laboratory personnel
conducting the tests did not have knowledge of the diabetes
status of any samples.
Statistical method
The s-IgA secretion rates (µg/min) were calculated as the
product of saliva volume (mL/min) and s-IgA concentration
(µg/mL). Because data did not fall into a normal distribution,
the s-IgA secretion rate was subjected to log transformation
before analysis. This strategy has been adopted in other
studies.22,23
To compare s-IgA secretion rates according to DM status,
we used an analysis of covariance and adjusted for variables
such as gender, assay batch (attended year), educational
background (under junior high school, high school, college
or higher, and unknown), smoking status (current smoker,
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ex-smoker, never smoker, and unknown), physical activity
(almost none, more than once a week, and unknown),
periodontitis (yes: CPI = 4; no: CPI < 4), and intake of any
medication (yes or no). We considered these variables as
confounding factors based on previous reports.15–17,22–25
Since the assay batch variable reﬂected inter-assay variation,
it could have been a potential confounder. Tests for linear
trends were conducted to assess associations between the
original continuous variables of HbA1c and s-IgA secretion
rate. All P values were two-tailed and considered statistically
signiﬁcant when P < 0.05. All statistical analyses were
performed using JMP Pro 10.0.2 software (SAS Institute
Inc., Cary, NC, USA).
RESULTS
Of 1209 men and 1097 women, 176 men (14.6%) and
77 women (7.0%) were categorized as having DM.
Characteristics of those with DM did not differ between
subjects who were eligible for participation and who were
excluded for producing too little saliva to assay (data not
shown). Table shows the distribution of participants according
to DM status. The proportion of patients with DM was low
among those with relatively high educational background.
Never having smoked tended to be associated with normal
DM status. Physical activity and CPI had no association with
DM status in this study. Medication intake was positively
associated with DM status.
The median s-IgA secretion rate was 35.7 µg/min (min:
0.0310 µg/min, max: 568 µg/min). Mean saliva volume did
not differ signiﬁcantly between normal, pre-DM, and DM
participants (data not shown).
Figure 1a shows the mean log s-IgA secretion rates
according to DM status after adjusting for minor
confounders, such as gender and assay batch. s-IgA
secretion rates were lower among participants with DM
than those classiﬁed as normal (18.6 µg/min vs 15.0 µg/min,
P = 0.03), even after elimination of the effects of all possible
confounders, such as assay batch, gender, educational
background, smoking status, physical activity, CPI, and
medication intake (Figure 1b). Low s-IgA secretion rate
also had a linear relationship (P for trend = 0.03) with high
HbA1c.
Table. Distribution of participants according to DM statusa
(n = 2306)
Normal (n = 1262) Pre-DM (n = 791) DM (n = 253)
Gender
Male 635 (50.3) 398 (50.3) 176 (69.6)
Female 627 (49.7) 393 (49.7) 77 (30.4)
Educational background
Junior high school or lower 395 (31.3) 235 (29.7) 75 (29.6)
High school 537 (42.5) 368 (46.5) 110 (43.5)
College or higher 316 (25.0) 184 (23.3) 65 (25.7)
Smoking status
Never smoker 712 (56.4) 425 (53.7) 101 (39.9)
Ex-smoker 336 (26.6) 222 (28.1) 104 (41.1)
Current smoker 214 (17.0) 143 (18.1) 48 (19.0)
Physical activity
Almost none 612 (48.5) 393 (49.7) 109 (43.1)
More than once a week 648 (51.4) 397 (50.2) 144 (56.9)
Community periodontal index
<4 1181, 93.58 742 (93.8) 238 (94.1)
4 81, 6.42 49 (6.2) 15 (5.9)
Receiving medication
No 540 (42.8) 314 (39.7) 61 (24.1)
Yes 722 (57.2) 477 (60.3) 192 (75.9)
DM, diabetes mellitus; FPG, fasting plasma glucose.
Values are expressed as numbers (%). Some factors have missing
values, so the totals are not always 100%.
aDM status was classiﬁed as, Normal: FPG < 6.1mmol/l and HbA1c <
5.6% (38mmol/mol); pre-DM: 6.1mmol/l ≤ FPG < 7.0mmol/l, or 5.6%
(38mmol/mol) ≤ HbA1c < 6.5% (48mmol/mol); DM: FPG ≥ 7.0mmol/l
or HbA1c ≥ 6.5% (48mmol/mol).
(a)
(b)
Figure 1. Mean (SD) log s-IgA secretion rate according
to diabetes mellitus (DM) status. Analyses
shown in Figure 1a were controlled for gender
and assay batch. Analyses in Figure 1b were
controlled for gender, assay batch, educational
background, smoking status, community
periodontal index, medication, and physical
activity. *P < 0.05.
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DISCUSSION
The present study is the ﬁrst to show an association between
DM and low s-IgA secretion rates in a large sample of older
people. The ﬁndings are important because of the increasing
number of DM patients and deaths from pneumonia in older
Japanese people.26,27
This cross-sectional study was developed from a previous
case-control study that showed that DM patients presented
with lower s-IgA levels than non-DM patients.13 Moreover,
our study assessed a large community sample of old people of
almost the same age controlled for possible confounders.
Potential mechanisms involved in the association between
DM and low s-IgA secretion rate are not clear. However, a
recent study revealed a link between low levels of peritoneal
B-1a cells and low production of IgM in DM mice.28
Experiments in vitro have conﬁrmed the causal relationship
of high concentrations of glucose on reduced secretion of total
IgM.28 Similar mechanisms may work to induce lower s-IgA
secretion rates in human DM patients’ salivary glands. More
female participants (n = 121) were excluded because too little
saliva was collected for assay than male participants (n = 62).
It is possible that more women had low salivary ﬂow and
suffered from xerostomia than men.25,29
Although the differences in s-IgA secretion rates between
normal status participants and those with DM status were
small, they were consistent and remained signiﬁcant
following adjustment for several variables known to have
some inﬂuence on the s-IgA secretion rate. They are also
of the same order of magnitude reported previously for
s-IgA secretion rates and stress.22,23 Nevertheless, whether
associations of this magnitude are of clinical signiﬁcance
remains unclear. A previous cohort study, although based on a
younger and smaller sample of athletes than the present study,
has shown that subjects prone to developing URTI had
signiﬁcantly lower saliva s-IgA secretion rates than URTI-free
subjects.5 This suggests that our ﬁndings might have some
clinical importance. Further prospective studies are needed to
clarify the nature of the associations between s-IgA secretion
rates and the development of other infectious diseases such as
URTI, pneumonia, and urinary tract infections.
The present study has several limitations. First, it is cross-
sectional and thus could not show a causal relationship
between hyperglycemia and low s-IgA secretion rates.
Second, we did not obtain information about the varieties or
frequencies of medications taken by participants. Many drugs,
such as diuretics, antihistamines, and anti-hypertension drugs,
are known to reduce saliva volume as an adverse side
effect.23,30 Subjects with DM status might take more
medications, which may itself result in reduced saliva
volume. However, in a restricted analysis of participants
who took no medication, DM was still associated with low
s-IgA secretion rate (data not shown). Therefore, the lack of
detailed information on medications taken might not have
affected our results. Third, the proportion of participants
strongly suspected to be DM patients (HbA1c ≥6.1% or
receiving medication for DM) in our study was 13.7% (17.0%
of men and 10.1% of women), which is close to the national
estimate in a similar age group in 2006 (13.6%; 14.7% in
men and 12.8% in women).31 However, the proportion of
participants who might be DM patients (HbA1c 5.6%–6.1%,
without receiving medication for DM) was 21.2% (20.7% in
men and 21.9% in women) in our study, which is slightly
higher than the national estimate (15.4%; 14.4% in men and
16.1% in women). Of note, however: differences in the
prevalence of diabetes or pre-diabetes would not affect the
association between DM and s-IgA secretion rate.
In conclusion, DM was associated with low s-IgA secretion
rate in the present study. Given the prominent role of s-IgA
in immune defense on mucosal surfaces and the frequency
with which infections are initiated on these surfaces, s-IgA
affords a pathway by which higher plasma glucose levels
might increase susceptibility to infectious diseases in DM
individuals. This result suggests that low s-IgA levels may be
a mechanism explaining susceptibility to infection in DM
individuals.
ACKNOWLEDGMENTS
The authors express their sincere appreciation to the Health
Center and Hygiene Department of Nisshin City for their
generous cooperation. We also gratefully acknowledge the
special efforts of the Nisshin Medical and Dental
Associations. We thank Dr. Mariko Naito for her advice on
our analysis. This study was supported by a Grant-in-Aid
for Scientiﬁc Research (B) from the Japanese Ministry of
Education, Culture, Sports, Science and Technology (MEXT;
no. 15390197). The authors report no potential conﬂicts of
interest relevant to this article.
J.O. conceived, analyzed, and wrote the manuscript. S.U.
helped with the analysis and reviewed the manuscript. H.O.
supervised saliva sample collection and IgA measurements.
K.W. and M.A. collected the data and coordinated the study.
T.K. designed and supervised the study, collected the data
and obtained funding. A.H. reviewed the manuscript. A.T.
designed and supervised the study, collected the data,
reviewed the manuscript, and obtained funding.
Conﬂicts of interest: None declared.
REFERENCES
1. Strugnell RA, Wijburg OL. The role of secretory antibodies in
infection immunity. Nat Rev Microbiol. 2010;8:656–67.
2. Woof JM, Mestecky J. Mucosal immunoglobulins. Immunol
Rev. 2005;206:64–82.
3. Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M,
Rezaei N, Yeganeh M, et al. IgA deﬁciency: correlation between
clinical and immunological phenotypes. J Clin Immunol.
2009;29:130–6.
Oikawa J, et al. 4
J Epidemiol 2015
4. Nieman DC, Henson DA, Dumke CL, Lind RH, Shooter LR,
Gross SJ. Relationship between salivary IgA secretion and upper
respiratory tract infection following a 160-km race. J Sports Med
Phys Fitness. 2006;46:158–62.
5. Gleeson M, Bishop N, Oliveira M, McCauley T, Tauler P,
Muhamad AS. Respiratory infection risk in athletes: association
with antigen-stimulated IL-10 production and salivary IgA
secretion. Scand J Med Sci Sports. 2012;22:410–7.
6. Klentrou P, Cieslak T, MacNeil M, Vintinner A, Plyley M.
Effect of moderate exercise on salivary immunoglobulin A and
infection risk in humans. Eur J Appl Physiol. 2002;87:153–8.
7. Benﬁeld T, Jensen JS, Nordestgaard BG. Inﬂuence of diabetes
and hyperglycaemia on infectious disease hospitalisation and
outcome. Diabetologia. 2007;50:549–54.
8. Leegaard A, Riis A, Kornum JB, Prahl JB, Thomsen VØ,
Sørensen HT, et al. Diabetes, glycemic control, and risk of
tuberculosis: a population-based case-control study. Diabetes
Care. 2011;34:2530–5.
9. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic
H, Genetet B. Impaired leucocyte functions in diabetic patients.
Diabet Med. 1997;14:29–34.
10. Sato N, Shimizu H, Suwa K, Shimomura Y, Kobayashi I, Mori
M. MPO activity and generation of active O2 species in
leukocytes from poorly controlled diabetic patients. Diabetes
Care. 1992;15:1050–2.
11. Ngo BT, Hayes KD, DiMiao DJ, Srinivasan SK, Huerter CJ,
Rendell MS. Manifestations of cutaneous diabetic micro-
angiopathy. Am J Clin Dermatol. 2005;6:225–37.
12. Boyko EJ, Fihn SD, Scholes D, Abraham L, Monsey B. Risk
of urinary tract infection and asymptomatic bacteriuria among
diabetic and nondiabetic postmenopausal women. Am J
Epidemiol. 2005;161:557–64.
13. Branco-de-Almeida LS, Alves CM, Lopes FF, Pereira Ade F,
Guerra RN, Pereira AL. Salivary IgA and periodontal treatment
needs in diabetic patients. Braz Oral Res. 2011;25:550–5.
14. Yavuzyilmaz E, Yumak O, Akdoğanli T, Yamalik N, Ozer N,
Ersoy F, et al. The alterations of whole saliva constituents in
patients with diabetes mellitus. Aust Dent J. 1996;41:193–7.
15. Evans P, Der G, Ford G, Hucklebridge F, Hunt K, Lambert S.
Social class, sex, and age differences in mucosal immunity in a
large community sample. Brain Behav Immun. 2000;14:41–8.
16. Waszkiewicz N, Zalewska A, Szajda SD, Waszkiewicz M, Szulc
A, Kepka A, et al. The effect of chronic alcohol intoxication and
smoking on the output of salivary immunoglobulin A. Folia
Histochem Cytobiol. 2012;50:605–8.
17. Akimoto T, Kumai Y, Akama T, Hayashi E, Murakami H, Soma
R, et al. Effects of 12 months of exercise training on salivary
secretory IgA levels in elderly subjects. Br J Sports Med.
2003;37:76–9.
18. Kitamura T, Kawamura T, Tamakoshi A, Wakai K, Ando M,
Ohno Y. Rationale, design, and proﬁles of the New Integrated
Suburban Seniority Investigation (NISSIN) Project: a study of
an age-speciﬁc, community-based cohort of Japanese elderly.
J Epidemiol. 2009;19:237–43.
19. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC,
Vandenbroucke JP; STROBE Initiative. The Strengthening the
Reporting of Observational Studies in Epidemiology (STROBE)
statement: guidelines for reporting observational studies. J Clin
Epidemiol. 2008;61:344–9.
20. American Diabetes Association. Diagnosis and classiﬁcation of
diabetes mellitus. Diabetes Care. 2013;36 Suppl 1:S67–74.
21. Kimura K, Ozeki M, Juneja LR, Ohira H. L-Theanine reduces
psychological and physiological stress responses. Biol Psychol.
2007;74:39–45.
22. Phillips AC, Carroll D, Evans P, Bosch JA, Clow A,
Hucklebridge F, et al. Stressful life events are associated with
low secretion rates of immunoglobulin A in saliva in the middle
aged and elderly. Brain Behav Immun. 2006;20:191–7.
23. Gallagher S, Phillips AC, Evans P, Der G, Hunt K, Carroll D.
Caregiving is associated with low secretion rates of
immunoglobulin A in saliva. Brain Behav Immun. 2008;22:
565–72.
24. Sloan CA, Engels HJ, Fahlman MM, Yarandi HE, Davis JE.
Effects of exercise on S-IGA and URS in postmenopausal
women. Int J Sports Med. 2013;34:81–6.
25. Eliasson L, Birkhed D, Osterberg T, Carlén A. Minor salivary
gland secretion rates and immunoglobulin A in adults and the
elderly. Eur J Oral Sci. 2006;114:494–9.
26. Japan Ministry of Health, Labour and Welfare [Internet]. Tokyo:
Vital statistics in Japan. [Updated 2013 July 19; cited 2014
Jun 23]. Available from: http://www.mhlw.go.jp/toukei/saikin/
hw/jinkou/geppo/nengai12/dl/gaikyou24.pdf (in Japanese).
27. Japan Ministry of Health, Labour and Welfare [Internet]. Tokyo:
National Health and Nutrition Survey. [Updated 2011 Jul 14;
cited 2014 Jun 23]. Available from: http://www.mhlw.go.jp/
bunya/kenkou/eiyou09/dl/01-kekka-01.pdf (in Japanese).
28. Jennbacken K, Ståhlman S, Grahnemo L, Wiklund O,
Fogelstrand L. Glucose impairs B-1 cell function in diabetes.
Clin Exp Immunol. 2013;174:129–38.
29. Nederfors T, Isaksson R, Mörnstad H, Dahlöf C. Prevalence of
perceived symptoms of dry mouth in an adult Swedish
population—relation to age, sex and pharmacotherapy.
Community Dent Oral Epidemiol. 1997 Jun;25:211–6.
30. Sreebny LM, Schwartz SS. A reference guide to drugs and dry
mouth—2nd edition. Gerodontology. 1997;14:33–47.
31. Japan Ministry of Health, Labour and Welfare [Internet]. Tokyo:
Vital statistics in Japan. [Updated 2010 July 23; cited 2014 Jun
23]. Available from: http://www.mhlw.go.jp/houdou/2008/04/
h0430-2.html (in Japanese).
Diabetes Mellitus is Associated With Salivary Immunoglobulin A Secretion Rates5
J Epidemiol 2015
